Radiotherapy may cause low-grade intestinal inflammation in cancer survivors

The grant will cover the manufacturing development of therapies by NK:IO in collaboration with the Cell and Gene Therapy Catapult. Credit: crystal light via Shutterstock. Innovate

Mod­er­na’s long-run­ning patent dis­pute with Pfiz­er and BioN­Tech in­ten­si­fied Tues­day af­ter Lon­don’s High Court of Jus­tice up­held one of Mod­er­na’s key mR­NA patents, but in­val­i­dat­ed